Japan Society for the Promotion of Science:Grants-in-Aid for Scientific Research
Date (from‐to) : 2014/04 -2017/03
Author : NAGAYA Yuko; KAWAGUCHI Yohei; OGURI Yusuke; TATEMATSU Naoe
Treatment of rheumatoid arthritis (RA) has advanced dramatically in the last decade, and it has become possible to aim for remission through strong treatment intervention such as biological and targeted anti-rheumatic drugs. However, there are drug-resistant patients who do not respond to any drug treatment. We have reported for the first time that gliostatin is closely involved in the pathogenesis of RA. In this study, we clarified that this gliostatin can be therapeutically targeted. The mechanism of joint destruction by gliostatin and its suppression mechanism were analyzed by molecular biological method using fibroblast-like synoviocytes derived from patients with RA